ADHD
-
ADHD, child and adolescent, Editor Nina Higson-Sweeney, environmental modification, European Child and Adolescent Psychiatry, lived experience, meta-ethnography, neuro-affirming approaches, neurodiversity, qualitative, Relationships, service transitions, social skills, systematic review, topical, youth mental healthADHD and the road to adulthood: what young people tell us about identity, support and transition
Imagine landing in an unfamiliar, roaring city. You have no map, the…
-
ADHD, adhd diagnosis, adult ADHD, clinical trials, comorbidity, diagnosis validity, diagnostic assessment, differential diagnosis, general psychopathology, Psychiatry, psychiatry methods, Psychology, randomized controlled trialsAdult ADHD Trials Often Skip Full Diagnostic Assessment
A 2025 scoping review of 292 adult ADHD randomized controlled trials found…
-
ADHD, aggression, anorexia nervosa, Anxiety, child and adolescent, digital health, digital mental health, Editor Nina Higson-Sweeney, immersive virtual reality, Internet Interventions, meta-analysis, serious games, substance use, systematic review, Virtual reality, youth mental healthImmersive VR therapy for young people: promising, but early days
Anyone who spends time with children and adolescents these days knows that…
-
ADHD, aggression, anorexia nervosa, Anxiety, child and adolescent, digital health, digital mental health, Editor Nina Higson-Sweeney, immersive virtual reality, Internet Interventions, meta-analysis, serious games, substance use, systematic review, Virtual reality, youth mental healthImmersive VR therapy for young people: promising, but early days
Anyone who spends time with children and adolescents these days knows that…
-
ADHD, amphetamines, atomoxetine, bupropion, clonidine, dexmethylphenidate, guanfacine, medication, medication safety, medicines, meta-analysis, methylphenidate, modafinil, network meta-analysis, neurodiversity, pharmacological intervention, psychopharmacology, Stimulants, systematic review, The Lancet Psychiatry, therapeutic inertia, viloxazineThe Goldilocks zone: getting ADHD medication ‘just right’
Neurodivergence, including Attention Deficit-Hyperactivity Disorder (ADHD), remains an area of great interest…
-
ADHD, amphetamines, atomoxetine, bupropion, clonidine, dexmethylphenidate, guanfacine, medication, medication safety, medicines, meta-analysis, methylphenidate, modafinil, network meta-analysis, neurodiversity, pharmacological intervention, psychopharmacology, Stimulants, systematic review, The Lancet Psychiatry, therapeutic inertia, viloxazineThe Goldilocks zone: getting ADHD medication ‘just right’
Neurodivergence, including Attention Deficit-Hyperactivity Disorder (ADHD), remains an area of great interest…
-
ADHD, Autism, bumetanide, Drugs, epilepsy, neurodevelopmental disorders, PROMIS, PROMset, Psychiatry, sensory reactivity, single-case experimental design, tuberous sclerosis complexBumetanide PROMset Study: 83% Improved in 1 Sensory-Related Domain
A 2026 medRxiv preprint using parent-cocreated sensory-related outcome measures found that 83%…
-
ADHD, Anxiety, child and adolescent, conduct disorder, cross-sectional, cross-sectional research, digital health, digital mental health, eating disorders, Editor Nina Higson-Sweeney, England, externalising problems, internalising problems, Nature Human Behaviour, registered report, Social media, topical, youth mental healthYoung people with mental health conditions use social media differently
In the past decade, mental health concerns in adolescents have been on…
-
ADHD, ADOS-2, Autism, Brain, connectome, default mode network, frontoparietal network, functional connectivity, gene expression, neurodevelopment, neuroscience, resting-state fMRI, symptom mapping, transdiagnostic psychiatryAutism vs. ADHD Connectome Study: Frontal-DMN Signal Tracks Autism Severity
A 166-child resting-state fMRI study found that clinician-observed autism severity, not ADHD…
-
ADHD, adverse events, antiseizure medication, Brain, children with epilepsy, Drugs, epilepsy, levetiracetam, neuroscience, oxcarbazepine, pediatric epilepsy, SV2A, therapeutic drug monitoring, topiramateLevetiracetam Range in Children: 2.82-24.37 mcg/mL TDM
A 2026 real-world study involving 1,174 children with epilepsy proposed a levetiracetam…
